Distek, Inc. Awarded U.S. Patent for Single-Use Bioreactor Design

NORTH BRUNSWICK, NJ - Oct 26, 2018 - Distek, Inc., a leading manufacturer of laboratory testing instruments for the pharmaceutical and biotechnology industry for over 40 years, has been awarded U.S. Patent 10,059,914 for their single-use bioreactor design. 

“This patent provides protection for our truly novel design. This invention provides the only true plug and play single use bioreactor for the benchtop market,” says Jeff Watkins, Director of Engineering, Distek, Inc.

Distek’s patented, single-use bioreactor system, also known as the BIOne, embodies a disposable bioreactor including a headplate and a stirrer.  The headplate has at least one inlet port aperture and one outlet port aperture formed therein and is adapted to couple sealingly with a bag capable of receiving a culture medium.  The stirrer is coupled to and extends from the headplate and is adapted to stir the culture medium when the headplate is coupled to the bag.  The bioreactor is adapted to fit within the upper opening of the stand of an existing conventional glass bioreactor, so that the bag is suspended within the vessel. 

“Our BIOne has sparked great excitement in the industry by filling an important customer need in terms of utilizing a single-use bag solution,” says Jeff Brinker, President.  “The acceptance of this patent continues to prove Distek’s commitment to providing innovative solutions for our customers in the biopharma industry.”

To learn more about Distek, Inc., its products and services, contact Distek’s Corporate Office at +1 732 422 7585, by email at bione@distekinc.com or visit www.distekinc.com.

ABOUT DISTEK, INC.

Distek engineers highly innovative, technically modern and user-friendly instruments that provide many innovative features to customers, worldwide.  These include: water bath and bathless dissolution, media preparation and disposal, in-situ fiber optic UV, bathless tablet disintegration, content uniformity and dissolution autosampling.  Distek’s bioprocessing portfolio includes the BIOne single-use bioreactor for cell culture applications as well as an innovative bioreactor control system for both mammalian and microbial models.

Distek’s core market includes brand name, generic and biosimilar drug manufacturers, CRO’s, CMO’s, Nutraceuticals, government agencies and universities. Distek holds several instrumentation and accessory patents and has been has been ISO certified since 2002.